IL13RA2 and glioblastoma: In one reported case, autologous CAR T cells targeting IL13Rα2 induced a complete response in a patient with recurrent multifocal glioblastoma, with dramatic improvements in quality of life and a return to normal life activities, allowing 7,5 disease free months survival [52].